Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on October 6, 2026

US Navy Veterans Lung & Mesothelioma Advocate Calls on the US Congress To Fund a Campaign to Warn Navy Veterans About the Dangers of Asbestos Exposure That Occurred to Millions of Vets Decades Ago--This is a May Day Call
Porch Light Health Awarded $6.6 Million Through Colorado Rural Health Transformation Program
TSC Life Receives FDA Clearance for Mistral-Air® MA1400 Forced Air Warming System
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Cerenome Launches CNSide® CSF Molecular Profile Tests
BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia
ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer
Zenas BioPharma to Host Virtual R&D Event
Why Do You Keep Gaining Weight Back After Losing It
F2G Announces Abstracts Accepted for Oral and Poster Presentation at IDWeek 2026
Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel
Shopify to Announce Third-Quarter 2026 Financial Results
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)
Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
MediciNova to Participate in the Maxim Growth Summit

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Potomac Health News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.